Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 8/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2720634 | 0.87 | DRD2 (0.40) | DRD2IDO1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2827735 | 0.83 | PPARA (0.36) | — | |
| SCHEMBL2829172 | 0.81 | — | — | |
| SCHEMBL2717619 | 0.75 | ALDH1A1 (0.33) | MCHR1SSTR4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2719722 | 0.73 | MAPT (0.35) | HIF1A | |
| SCHEMBL2836770 | 0.73 | MAPT (0.35) | HIF1A | |
| SCHEMBL11967019 | 0.72 | ALDH1A1 (0.40) | HIF1A | |
| SCHEMBL2720805 | 0.71 | ALDH1A1 (0.50) | MCHR1SSTR4HIF1A | |
| SCHEMBL16954211 | 0.70 | HIF1A (0.40) | SSTR4SLC6A2SLC6A4SLC6A3HIF1A | |
| SCHEMBL6021886 | 0.70 | TDP1 (0.42) | HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160555-A1 | RESIN COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-2133380-A1 | RESIN COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090018355-A1 | Process for Crystallizing an Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LTD. | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018355-A1 | Process for Crystallizing an Epoxy Compound | PTGER1, NR5A1, TCP1 | MCHR1 1198/4885DRD2 942/4885SSTR4 2969/4885 |
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | MCHR1 621/4885DRD2 166/4885SSTR4 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.